Cubist Systematic Strategies, LLC Insmed Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Insmed Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 191,229 shares of INSM stock, worth $14 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

191,229

Previous 38,700 394.13%

Holding current value

$14 Million

Previous $2.59 Million 438.54%

% of portfolio

0.09%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $11.9 Million - $15.1 Million	191,229 New	191,229 $14 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $2.77 Million - $3.22 Million	-107,584 Reduced 61.58%	67,111 $1.82 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $2.23 Million - $3.02 Million	-95,151 Reduced 35.26%	174,695 $5.41 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $5.17 Million - $7.01 Million	260,177 Added 2690.84%	269,846 $6.81 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $158,958 - $204,015	9,669 New	9,669 $204,000
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $5.88 Million - $8.02 Million	-346,270 Reduced 89.64%	40,035 $799,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $7.02 Million - $9.48 Million	336,132 Added 669.95%	386,305 $8.32 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $707,483 - $1.07 Million	41,446 Added 474.92%	50,173 $989,000
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $1.75 Million - $2.42 Million	-85,891 Reduced 90.78%	8,727 $205,000
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $1.96 Million - $2.53 Million	75,630 Added 398.3%	94,618 $2.58 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $408,120 - $535,499	18,171 Added 2224.11%	18,988 $523,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $245,591 - $365,897	-10,161 Reduced 92.56%	817 $23,000
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $252,591 - $346,647	-7,825 Reduced 41.62%	10,978 $374,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $1.3 Million - $1.67 Million	-41,193 Reduced 68.66%	18,803 $626,000
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $1.39 Million - $1.84 Million	53,396 Added 809.03%	59,996 $1.93 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $733,663 - $1.53 Million	-51,996 Reduced 88.74%	6,600 $182,000
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $728,496 - $1.82 Million	53,448 Added 1038.23%	58,596 $939,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $228,130 - $353,516	-14,152 Reduced 73.33%	5,148 $123,000
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $102,048 - $169,838	6,588 Added 51.83%	19,300 $340,000
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $137,425 - $192,335	5,975 Added 88.69%	12,712 $325,000
Q1 2019 May 15, 2019	SELL	$13.91 - $31.15 $721,386 - $1.62 Million	-51,861 Reduced 88.5%	6,737 $196,000
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $590,347 - $951,680	50,892 Added 660.42%	58,598 $769,000
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $14,439 - $21,396	-762 Reduced 9.0%	7,706 $156,000
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $169,360 - $251,668	8,468 New	8,468 $200,000
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $50,851 - $61,144	-1,924 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $22,337 - $60,048	1,924	1,924 $60,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.94B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Insmed Inc Transaction History